A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...

Managing diabetes comes with a variety of challenges, and one of the most significant obstacles many patients face is the ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Ozempic, which accounts for 41% of the company's sales, is an injectable anti-diabetic treatment that became wildly popular ...

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs used to treat people with type 2 diabetes. The drugs, classified as GLP-1 agonists, have also been used for weight loss in ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...